All Speakers: 2014 to 2018
Find below all the speakers who have done us the honor to participate in the Prix Galien
| FIRST NAME | LAST NAME | FONCTION | CIE / INSTITUTION | YEAR |
|---|---|---|---|---|
| Anna K. | Abram | Deputy Commissioner for Policy, Planning, Legislation and Analysis | FDA | 2018 |
| Sarah | Akerman | M.D., Senior Medical Director | Alkermes | 2018 |
| Charles | Albright | PhD, Chief Scientific Officer | Editas Medicine, Inc. | 2016 |
| David | Altshuler | Dr | Massachussets General Hospital and Blood Institute | 2013 |
| David | Anderson | PhD, Professor of Biology, Howard Hughes Medical Institute | California Institute of Technology | 2014 |
| Douglas | Andrews | CEO and Director | Stravencon | 2012 |
| Abel | Archundia | MBA, Global Head of IT & Digital Transformation | Bayer Pharmaceuticals | 2019 |
| David | Artis | PhD, Director, Roberts Institute for Research in Inflammatory Bowel Disease | Weill Cornell Medical College | 2015 |
| Hala | Audi | Head of Secretariat, UK Review on Antimicrobial Resistance Richard Axel, MD, Nobel Laureate, Co-Director, Kavli Institute for Brain Science, Columbia University Medical Center; Investigator | Howard Hughes Medical Institute | 2014-2016 |
| Christopher | Austin | Director, National Center for Advancing Translational Sciences | National Institutes of Health | 2013 |
| Richard | Axel | MD, Nobel Laureate; Co-Director, Kavli Institute for Brain Science | Columbia University Medical Center | 2014 / 2015 |
| Peter | Bach | MD, Director, Center for Health Policy and Outcomes | Memorial Sloan-Kettering Cancer Center | 2017 |
| John | Baldoni | PhD, Senior Vice President, DPU Head, ln Silico Discovery | GSK Pharmaceuticals | 2018 |
| Corey | Bargmann | PhD | The Rockefeller University | 2014 |
| José | Baselga | MD, PhD, Physician-in-Chief & Chief Medical Officer, Memorial Sloan Kettering Cancer Center,Director, Board of Directors | GRAIL, Inc. | 2017 |
| Frank C. | Bennett | PhD, Senior Vice-President of Research | Ionis Pharmaceuticals | 2017 |
| Jeffery | Berkowitz | SVP Pharmaceutical Development and Market Access | Walgreens | 2011 |
| Emily | Bernstein | PhD, Professor | Ivahn School of Medicine at Mount Sinai | 2014 |
| Kathie M. | Bishop | PhD, Chief Scientific Officer | Otonomy | 2017 |
| Cheryl R. | Blanchard | PhD, CEO, MicroCHIPS | Biotech, Inc. | 2015 |
| Carina | Blomström-Lundqvist | PhD, Professor of Cardiology | Uppsala University, Sweden | 2017 |
| Jeff | Bluestone | Professor, Head, Diabetes Center, and Provost | UCSF | 2014 |
| Michael | Bonney | Partner | Third Rock Ventures, LLC | 2016 |
| Alexis | Borisy | Partner | Third Rock Ventures | 2018 |
| Albert | Bourla | DVM, PhD, Chief Executive Officer | Pfizer | 2019 |
| Marc M. | Boutin | JD, Chief Executive Officer | National Health Council | 2018 |
| Karin | Briner | PhD, Vice President & Head, Global Discovery Chemistry | Novartis | 2019 |
| Michael S. | Brown | Professor & Director, Jonsson Center for Molecular Genetics | UT Southwestern Medical Center, Dallas | 2011 / 2013 / 2014 |
| Paula | Brown Stafford | M.Ph., Chief Development Officer, Novan, Inc. & Adjunct Professor of Public Health Leadership | University of North Carolina, Chapel Hill, Co-Founder of Habergeon LLC | 2018 |
| Samantha | Budd | Dr, Vice President, Neuroscience iMed, | AstraZeneca R&D | 2013 |
| Jaime | Burnes | Managing Director, Healthcare Investment Banking | Cowen Group | 2011 |
| Amy K. | Butler | PhD, President of Biosciences | Thermo Fisher Scientific | 2019 |
| Sean | Caffey | MD, MBA, Co-Founder, Chairman & CEO, Auricle, LLC; Co-Founder & Chairman | Replenish, Inc. | 2015 |
| Robert M. | Califf | Dr, Vice Chancellor for Clinical and Translational Medicine Director of Duke Translational Medicine Institute (DMTMI) and Professor of Medicine in the Division of Cardiology Duke University | 2013 | |
| John | Camm | MD, Professor of Clinical Cardiology | St George’s, University of London | 2017 |
| John | Castellani | President & Chief Executive Officer | Pharmaceutical Research and Manufacturers of America (PhRMA) | 2012 |
| Satty | Chandrashekhar | Managing Director and Partner | Boston Consulting Group | 2019 |
| Paul | Chew | Dr, Sr Vice President, CSO/CMO | Sanofi Aventis | 2010 |
| Alessio | Ciulli | PhD, Professor of Chemical & Structural Biology, School of Life Sciences | University of Dundee | 2019 |
| Ron | Cohen | Dr, President and CEO | Acorda Therapeutics | 2010 |
| Rory | Collins | FRS, FMedSci, Head, Nuffield Department of Population Health and BHF Professor of Medicine and Epidemiology | University of Oxford | 2014 |
| Meryl | Comer | President | Geoffrey Beene Foundation Alzheimer’s Initiative | 2012 |
| Craig | Crews | PhD, Founder and Chief Scientific Officer | Arvinas | 2019 |
| Glenn | D. Steele | Jr., MD, PHD, President and CEO | Geisinger Health System | 2015 |
| Stephen | Daniels | MD, PhD, MPH, Professor and Chair, Department of Pediatrics | University of Colorado | 2011 |
| Alice | Dautry | Ph.D., Director, General | Institut Pasteur | 2012 |
| Brett | Davis | Senior Director, Personalized Healthcare, Health Sciences Global Business Unit | Oracle Corporation | 2011 |
| Geraldine | Dawson | PhD, Professor & Director, Duke Center for Autism and Brain Development | Duke University Medical Center | 2015 |
| Neil | De Crescenzo | SVP and General Manager | Oracle Health Sciences | 2012 |
| Darryl | De Vivo | MD, Sidney Carter Professor of Neurology and Pediatrics | Columbia University Medical Center | 2017 |
| Glen | De Vries | President, Medidata Solutions Worldwide | Medidata Solutions, Inc. | 2014-2016 |
| Karl | Deisseroth | MD, PhD, Chen Professor | Stanford University | 2014 |
| George D. | Demetri | M.D., Senior Vice President for Experimental Therapeutics, Dana-Farber Cancer Institute; Professor of Medicine & Director, Ludwig Center, Harvard Medical School; Associate Director for Clinical Sciences, Dana-Farber | Harvard Cancer Center | 2018 |
| Alex | Depaoli | MD, Vice President of Translational Research | NGM Biopharmaceuticals | 2011 |
| Nancy-Ann | Deparle | JD, Partner | Consonance Capital Partners | 2015 |
| Susan | Desmond-Hellmann | MD, MPH, Chief Executive Officer | Bill & Melinda Gates Foundation, Prix Galien USA Committee Chair | 2018 / 2019 |
| Marc | Diamond | MD, Distinguished Chair in Basic Brain Injury and Repair and Director, Center for Alzheimer’s and Neurodegenerative Disease | University of Texas, Southwestern Medical Center | 2017 |
| Sir Andrew | Dillon | Chief Executive | National Institute for Health and Care Excellence (NICE), UK | 2018 |
| Mikael | Dolsten | MD, PhD, Chief Scientific Officer & President, Worldwide Research, Development and Medical (WRDM) | Pfizer | 2013 / 2014 / 2016 / 2017 / 2018 / 2019 |
| William | Doyle | MBA, Executive Chair, NovoCure, Ltd.; Co-Founder & Managing Partner, WFD Ventures LLC; Member | Pershing Square Capital, LP | 2015 |
| Nancy | Dreyer | PhD, MPH, FISPE, Fellow DIA, Chief Scientific Officer | IQVIA | 2019 |
| Daniel | Drucker | MD, Senior Scientist, Lunenfeld Tanenbaum Research Institute | Mount Sinai Hospital, Toronto, Ontario | 2016 |
| Paul | Eisenberg | Dr, Sr Vice President, Global Regulatory Affairs and Safety | Amgem | 2010 |
| Ezekiel | Emmanuel | MD, PhD, Vice Provost for Global Initiatives & Chair, Medical Ethics and Health Policy Levy, Perelman School of Medicine & Wharton School | University of Pennsylvania | 2014 |
| David R. | Epstein | MBA, Executive Partner, Flagship Pioneering | Flagship Pioneering | 2016 / 2019 |
| Robert S. | Epstein | M.D., Chief Clinical Research and Development Officer | Medco Health Solutions, Inc. | 2011 |
| Mark | Feinberg | MD, PhD, President and CEO | The International AIDS Vaccine Initiative (IAVI) | 2017 |
| David | Feltquate | MD, PhD, Vice President, Immuno- Oncology | Bristol-Myers Squibb | 2016 |
| Adolfo | Ferrando | MD, PhD, Professor, Institute for Cancer Genetics | Columbia University Medical Center | 2014 |
| Mauro | Ferrari | Ph.D., Chair, Ernest Cockrell Jr. Presidential Distinguished Chair, President and Chief Executive Officer, Houston Methodist Research Institute, Executive Vice President | Houston Methodist Hospital System | 2018 |
| Michael | Fischbach | Ph.D., Associate Professor of Bioengineering | Stanford University | 2018 |
| Martin | Fitchet | MD, Chief Operating Officer, Pharmaceutical Research & Development | Johnson & Johnson, | 2011 |
| Emmanuel | Fombu | MD, MBA, Physician, Author: The Future of Healthcare | 2019 | |
| Jean Francois | Formela | MD, Partner | Atlas Ventures | 2017 |
| Richard | Foster | PhD, Venture Partner, Lux Capital; Special Advisor for Health Innovation, Yale University; Director Emeritus | McKinsey & Co. | 2014 |
| Jacqualyn | Fouse | PhD, Chief Executive Officer | Agios | 2019 |
| Kenneth C. | Frazier | JD, CEO and Chairman | Merck & Co. Inc. | 2013 / 2015 |
| O.H. (Bud) | Frazier | MD, Chief of Cardiopulmonary Transplantation, Program Director and Chief, Center for Cardiac Support, and Director of Cardiovascular Surgery Research, Texas Heart Institute; Chief of Transplant Service | St. Luke’s Episcopal Hospital | 2015 |
| Maria C. | Freire | PhD, President & Executive Director | Foundation for the National Institutes of Health | 2012 / 2016 |
| Jeffrey | Friedman | MD, PhD, Marilyn M Simpson Professor, Investigator Howard Hughes Medical Institute, Laboratory of Genetics | The Rockefeller University | 2011 |
| Maria | Friere | PhD, President & Executive Director | Foundation for the National Institutes of Health | 2016 |
| Les | Funtleyder | Fund manager | Polliwog | 2011 / 2012 |
| John | Furey | Chief Operating Officer | Spark Therapeutics Inc. | 2018 |
| Julie | Gerberding | M.D., MPH, President, Merck Vaccines, Former Director | Merck & Co Inc, Disease Control and Prevention (CDC) | 2012 |
| Barry | Gertz | MD, PhD., SVP, head of clinical research and regulatory affairs | Merck | 2011 |
| Walter | Gilbert | PhD, Nobel Laureate | Harvard University | 2011 |
| Michael | Giordano | MD, Senior Vice President & Head of Development, Oncology and Immunoscience | Bristol-Myers Squibb | 2014 |
| Laurie H. | Glimcher | MD, Dean & Professor | Weill Cornell Medical College | 2014 / 2015 |
| Laurie | Glimcher | Pr, Cornell Provost for Medical Affairs and Dean | Medical College, New York | 2013 |
| Joseph | Goldstein | Nobel Laureate, Professor of Molecular Genetics & Internal Medicine | UT Southwestern Medical Center at Dallas | 2011 / 2013 / 2014 |
| Jeffrey I. | Gordon | MD, Professor and Director, Center for Genome Sciences and Systems Biology | Washington University, St. Louis | 2015 |
| Alex | Gorsky | Chairman and CEO | Johnson & Johnson | 2013 |
| Scott | Gottlieb | MD, Former Commissioner | U.S. FDA | 2019 |
| Maria | Grazia Roncarolo | MD, Professor of Pediatrics and Medicine | Stanford University School of Medicine | 2019 |
| Paul | Greengard | PhD, Nobel Laureate | Rockefeller University | 2010 / 2011 |
| Philip D. | Gregory | Ph.D., Chief Scientific Officer | Bluebird | 2018 |
| Scott | Grundy | Center for Human Nutrition | UT Southwestern Medical Center | 2014 |
| Kimberly | Ha | Global Editor | Biopharm Insight | 2011 / 2012 |
| William | Hait | MD, PhD, Global Head, R&D | Janssen R&D | 2014 |
| John E. | Hambor | PhD, Director of Research Beyond Borders | Boehringer Ingelheim | 2015 |
| Margaret | Hamburg | MD, Former Commissioner | U.S. Food and Drug Administration | 2012 / 2015 / 2016 |
| Patrice A. | Harris | M.D., M.A., President-elect | American Medical Association | 2018 |
| Fred | Hassan | M.D. | P. Roy Vagelos | 2012 |
| Richard | Hatchett | MD, CEO | The Coalition for Epidemic Preparedness Initiative (CEPI) | 2017 |
| Michael | Heffernan | Chairman | Collegium Pharmaceutical | 2018 |
| Thomas | Heffner | Dr, Executive Director of Worlwide Business Development | Pfizer | 2010 |
| Karl | Hick | Chief Digital and Information Officer | Takeda | 2019 |
| Kathy | High | MD, President and Head of R&D | Spark Therapeutics | 2019 |
| Kathy | High | President and head of Research and Development | Spark Therapeutics | 2018 |
| R.T. (Terry) | Hisey | Vice Chairman & US Life Sciences Leader | Deloitte LLP | 2012 |
| David | Holtzman | Dr, Andrew B. And Gretchen P. Jones Professor and Chairman of Neurology, Professor of Developmental Biology, Associate Director Alzheimer's Disease Research Center | Washington University | 2013 |
| Peter | Honing | Dr, Head Global Regulatory Affairs | Astra Zeneca | 2010 |
| Herve | Hoppenot | President Novartis Oncology | Novartis Pharmaceuticals Corporation | 2013 |
| Scott | Howell | M.D., M.B.A., Vice-President and Head, US Market Access | Novartis Pharmaceuticals Inc. | 2018 |
| Clifford | Hudis | MD, CEO | American Society of Clinical Oncology | 2016 |
| Mark | Hulse | RN, Vice President Information Technology and Chief Information Officer | Moffitt Cancer Center | 2011 |
| Stephen | Hume | M.D., a leading clinician and a patient with early onset Alzheimer’s disease | 2012 | |
| Andrew | Jack | Moderator | Financial Times | 2012 |
| Sanchin | Jain | MD, MBA, Chief Medical Information &Innovation Officer, Merck & Co.; Lecturer | Harvard Medical School | 2014 |
| Joanne | Jiang | Co-founder | Fountain Medical Development | 2012 |
| Kris | Joshi | PhD, Global Vice President | Healthcare Oracle Health Sciences | 2012 / 2013 |
| Carl H. | June | Dr, Director of Translational Research at the Abramson Cancer Center | University of Pennsylvania | 2013 |
| Kenneth | Kaitin | Dr, Director | Tufts Center for the Study of Drug Development | 2010 |
| Eric | Kandel | PhD, Nobel Laureate, Professor and Fred Kavli Professor, Department of Neuroscience | Columbia University, New York | 2010 / 2011 / 2017 |
| Brian | Kaspar | Ph.D., Scientific Founder and Chief Scientific Officer | AveXis, Inc. | 2018 |
| Russell | Katz | M.D., Director, Division of Neurology Products, Center for Drug Evaluation and Research | U.S. Food and Drug Administration | 2012 |
| Mark | Kessel | Managing Directory | Symphony Capital LLC | 2010 |
| Kostas | Kidos | Vice President, Safety and PV Strategy | Oracle Corporation | 2010 |
| David | Koch | Institute Professor | Massachusetts Institute of Technology | 2018 |
| Jean-Pierre A. | Kocher | Ph.D. Head, The Bioinformatics Core (BIC) | Mayo Clinic | 2012 |
| Adrian R. | Krainer | PhD, St. Giles Foundation Professor of Molecular Genetics, Program Chair, Cancer & Molecular Biology | Cold Spring Harbor Laboratory, Watson School of Biological Sciences | 2017 |
| Jörg | Kreuzer | Therapeutic Area Head Medicine CV | Boehringer Ingelheim Pharma GmbH & Co. KG | 2017 |
| William | Kridel | Partner | Ferghana Partners | 2011 / 2012 |
| Mark | Kris | Dr, Chief, Thoracic Oncology Services | Memorial Sloan Kettering Cancer Center, New York | 2013 |
| Jim | Krueger | MD, PhD, Laboratory for Investigative Dermatology | Rockefeller University | 2017 |
| Story | Landis | PhD, Chair, Former Director | National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH), and Co-Founder, NIH BRAIN Initiative | 2017 |
| Robert S. | Langer | M.D., Ph.D., Chair, | Massachusetts Institute of Technology | 2015 / 2018 |
| Stanley N. | Lapidus | President, CEO, and Co-Founder | SynapDx Corporation | 2014-2016 |
| Martin | Leach | Chief Information Officer | Broad Institute, MIT and Harvard | 2012 |
| John | Lechleiter | Dr, Chairman, and CEO | Eli Lilly & Company | 2013 |
| Jonathan | Leff | MBA, Partner | Deerfield Institute | 2016 |
| Jeffrey | Leiden | Dr, Chairman, President and CEO | Vertex | 2013 |
| John | Leonard | MD, Chief Medical Officer | Intellia Therapeutics, Inc. | 2016 |
| Richard A. | Lerner | M.D | Scripps Research Institute | 2011 |
| Nick | Leschly | MBA, President and CEO | Bluebird Bio, Inc. | 2015 |
| Richard | Lifton | Dr, Professor | Yale University School of Medicine | 2013 |
| Rodolfo R. | Linas | Pr, MD, PhD, Chairman, Department of Physiology & Neuroscience | New York University | 2010 |
| Dan R. | Littman | MD, PhD, Investigator, Howard Hughes Medical Institute Kimmel Professor of Molecular Immunology Skirball Institute of Biomolecular Medicine | New York University School of Medicine | 2017 / 2018 |
| Donald | Lloyd-Jones | Chairman, Department of Preventative Medicine | Northwestern University | 2014 |
| Peter D. | Loftus | Dow Jones Newswires reporter covering pharmaceutical industry; contributor | Wall Street Journal | 2011 |
| Roger | Longman | Moderator | 2011 / 2012 | |
| Julie | Louise Gerberding | MD, MPH, Chair, Executive Vice-President, Chief Patient Officer and Head of Policy, Communications, and Population Health | Merck & Co., Inc. | 2017 |
| Jan | Lundberg | Dr, Executive Vice President, Science and Technology and President | Lily Research Labs, Lilly & Co | 2013 |
| Charles R. | Mackay | PhD, Chief Scientific Officer, Inflammation and Immunology Research Unit | Pfizer, Inc. | 2015 |
| Sandy | Macrae | PhD, President & CEO, Sangamo | BioSciences | 2016 |
| Joel S. | Marcus | Executive Chairman & Founder, Alexandria Real, Estate Equities, Inc./ Alexandria Venture Investments; Co-Founder, Alexandria Summit | Alexandria | 2012 / 2013 / 2014 / 2015 / 2016 / 2017 / 2018 / 2019 |
| Michael | Mark | PhD, Vice President& Global Head, Cardio Metabolic Diseases Research | Boehringer Ingelheim | 2016 |
| Peter | Marks | MD, PhD, Director, Center for Biologics Evaluation and Research (CBER) | U.S. FDA | 2018 / 2019 |
| Lynn | Marks | M.D., Senior Vice President, Medicines Development Center for Infectious Diseases | GlaxoSmithKline plc | 2012 |
| Paul A. | Marks | Dr, President, Emeritus, Laboratory Head of Cell Biology | Memorial Sloan Kettering Cancer Center, New York | 2011 / 2013 |
| Sarkis K. | Mazmanian | PhD, Luis B. and Nelly Soux Professor of Microbiology | California Institute of Technology (Caltech) | 2015 / 2018 |
| Corey | Mccann | M.D., Ph.D., President and Chief Executive Officer | Pear Therapeutics | 2018 |
| Mark | Mcclellan | MD, PhD, Director, Duke-Robert J. Margolis Center for Health Policy | Duke University | 2014 / 2016 |
| John | Mcmurray | MD, Professor, Institute of Cardiovascular and Medical Sciences | University of Glasgow | 2015 |
| Ira | Mellman | Dr, Vice President, Research Oncology | Genentech | 2013 |
| Steve | Miller | MD, Senior Vice President and Chief Medical Officer | Express Scripts | 2017 |
| Gerard | Nahum | M.D., Vice President, Global Clinical Development for Medical Devices & eHealth, | Bayer Pharmaceuticals | 2018 |
| Ameet | Nathwani | MBBS, MRCP, Senior Vice President and Global Head of Medical Affairs | Novartis | 2015 |
| Lee N. | Newcomer | M.D., Principal, Lee Newcomer Consulting LLC; Former Senior Vice President, Oncology and Genetics | UnitedHealthcare | 2018 |
| William | Newsome | PhD, Professor | Stanford University | 2014 |
| Steven | Nissen | M.D., M.A.C.C., Chairman, Department of Cardiovascular Medicine Cleveland Clinic Foundation and Professor of Medicine, Cleveland Clinic Lerner School of Medicine at Case Western Reserve U. | Cleveland Clinic Foundation, Cleveland Clinic Lerner School of Medicine | 2011 |
| Larry | Norton | MD, Deputy physician-in-chief for breast cancer programs and medical director, Evelyn H. Lauder Breast Center | Memorial Sloan-Kettering Cancer Center | 2011 |
| Tara | Nuala | MD, FACC, Moderator & Medical Constributor | CBS This Morning | 2014 |
| Stephen N. | Oesterle | MD, Senior Vice President of Medicine and Technology | Medtronic | 2015 |
| Joshua J. | Ofman | MD, MSHS, Chief of Corporate Strategy and External Affairs | GRAIL | 2019 |
| Bernat | Olle | Ph.D., Chief Executive Officer | Vedanta Biosc | 2018 |
| Ülo | Palm | MD, PhD, MBA, Senior Vice-President, Digital Sciences | Allergan | 2019 |
| Ed | Park | Executive Vice President 7 COO | Athenahealth, Inc. | 2014 |
| Roy | Parker | PhD, Professor Cech-Leinwand Endowed Chair of Biochemistry | University of Colorado, Boulder | 2017 |
| Steven | Paul | MD, President and CEO | Voyager Therapeutics | 2015 |
| Steve | Pearson | MD, Founder and President | Institute for Clinical and Economic Review (ICER) | 2017 |
| Magnus | Persson | MD, PhD, Managing Partner | The Column Group | 2011 |
| Jennifer | Petter | PhD, Chief Scientific Officer | Arrakis | 2019 |
| Seth | Pinsky | President, | New York City Economic Development Corporation (NYCEDC) | 2010 |
| Gary | Pisano | Ph.D., Harry E. Figgie Professor of Business Administration | Harvard Business School | 2018 |
| Peter J. | Pitts | President | Center for Medicine in the Public Interest | 2011 |
| William | Potter | M.D., Ph.D., Senior Advisor | National Institute of Mental Health | 2012 |
| Richard | Pr, Nobel Laureate, Co-Director, The Kavli Institute For Brain Science | Columbia University Medical Center, New York | 2013 | |
| Stanley | Prusiner | MD, Chair, Nobel Laureate, Professor of Neurology and Biochemistry | University of California, San Francisco (UCSF) | 2017 |
| Mark | Pykett | President and Chief Executive Officer | Neoprobe Corporation | 2011 |
| Paul I. | Rachlin | Partner | Proskauer | 2011 |
| Daniel | Rader | Professor of Medicine | University of Pennsylvania | 2014 |
| Guido | Rasi | Executive Director | European Medicines Agency | 2012 |
| Vivek | Reddy | MD, Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology, | Icahn School of Medicine, Mount Sinai | 2017 |
| Robert H | Ring | hD, Chief Science Officer | Autism Speaks | 2015 |
| Michael | Ringel | JD, PhD, Senior Partner & Managing Director | BCG | 2019 |
| Michael | Ringel | PhD, JD, Senior Partner & Managing Director | BCG | 2018 |
| Maryanne | Rizk | PhD, Senior Vice President Digital R&D Strategy | IQVIA | 2019 |
| Kent | Rogers | M.B.A., Senior Vice President, Industry Relations | UnitedHealth Group Inc. | 2018 |
| Dana | Rollison | Ph.D., Vice President, Total Cancer Care and Chief Health Information Officer | Moffitt Cancer Center | 2011 |
| Steve | Rosenberg | Senior Vice President & General Manager | Oracle Health Sciences | 2018 / 2019 |
| Mike | Rosenblatt | MD, Chief Medical Officer | Flagship Pioneering | 2011 / 2012 / 2013 / 2018 / 2019 |
| Hans | Rosling | Professor | Karolinska Institutet | 2014 |
| Sergio | Rossi | MBA, Managing Director & Partner | Boston Consulting Group | 2019 |
| John W. | Rowe | MD, Julius B. Richmond Professor of Health Policy and Aging, Mailman School of Public Health | Columbia University | 2015 |
| Francesco | Rubino | MD, Associate Professor of Surgery, Director, Metabolic & Diabetes Surgery Center | Weill Cornell Medical College | 2011 |
| Lars | Rydén | MD, Dr h.c., HMRCP, FESC, FACC, FAHA, Senior Professor of Cardiology | Karolinska Institute, Stockholm, Sweden | 2015 / 2016 / 2017 |
| Michel | Sadelain | MD, PhD, Director, Center for Cell Engineering | Memorial Sloan Kettering Cancer Center | 2016 |
| Bengt | Samuelsson | MD, PhD, Nobel Laureate, Former President, Karolinska Institute, Former Chairman, Nobel Foundation | Karolinska Institute, Nobel Foundation | 2011 / 2013 / 2014 / 2015 / 2016 / 2017 / 2019 |
| Alfred | Sandrock | MD, PhD, Executive Vice-President and Chief Medical Officer | Biogen | 2017 |
| Luca | Santarelli | MD, Former Senior Vice President, Head of Neuroscience, Ophthalmology & Rare Diseases (NORD), Roche Pharma Research & Early Development | Roche | 2015 |
| Troy | Sarich | PhD, Global Head Janssen R&D Strategy | Janssen Research & Development | 2018 |
| Nadeem | Sarwar | MRPharmS Ph.D., Senior Director – Head, Population Research & Head, Cardiovascular Genetics | Pfizer | 2012 |
| George | Scangos | PhD, CEO | Biogen | 2014 |
| David | Schenkein | MD, General Partner, Google Ventures; Executive Chairman of the Board & Former Chief Executive Officer, | Agios Pharmaceuticals | 2018 / 2019 |
| Julie | Schiffman | MBA, Vice President, Global Business Analytics | Pfizer | 2018 |
| Leonard | Schleifer | MD, PhD, Founder, President and CEO | Regeneron Pharmaceuticals | 2017 |
| David | Schleifer | M.D., Chief Executive Officer | Agios Pharmaceuticals | 2017 |
| Jim | Scholefield | MBA, Executive Vice President, Chief Information and Digital Officer | Merck & Co | 2019 |
| Dennis | Selkoe | M.D., Co-Director, Center for Neurological Diseases, Brigham and Women’s Hospital, and Vincent and Stella Coates Professor of Neurologic Diseases | Harvard Medical School | 2012 |
| Magnus | Settergren | MD, PhD, Assoc Prof and Interventional Cardiologist | Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden | 2019 |
| Gaurav | Shah | President and Chief Executive Officer | Rocket Pharmaceuticals, Inc. | 2018 |
| Jonathan | Sheldon | PhD, Global Vice President, Healthcare, Health Sciences Global Business Unit | Oracle | 2014 / 2015 / 2016 |
| Jonhathan | Sheldon | Dr, Global Senior Director of Translational Medicine | Oracle Health Sciences | 2013 |
| Morgan | Sheng | Dr, Vice President, Neuroscience | Genentech | 2013 |
| Elliott | Sigal | Dr, Former Executive Vice President, Chief Scientific Officer and President, R&D | BMS | 2013 |
| Jonathan | Silverstein | Partner | OrbiMed Advisors | 2010 / 2011 |
| Laura | Slatkin | Founder and CEO, NEST Fragrances; Co-Founder and Board President | New York Collaborates for Autism | 2015 |
| Robin L. | Smith | MD, MBA, Founder | Neostem and Cura Foundation | 2019 |
| Reisa | Sperling | Dr, Professor of Neurology | Harvard Medical School Department of Neurology, Brigham and Women's Hospital | 2013 |
| Richard | Staub | President of Research and Development Solutions | IQVIA | 2019 |
| Steven | Stein | MD, Senior Vice President, US Clinical Development and Medical Affairs | Novartis Oncology | 2014 |
| Scot | Stevens | Chief Information Officer, UPMC CancerCenter & UPCI, Director Personalized Medicine Technology, | UPMC | 2012 |
| Eliane | Strosberg | MD., PhD. | 2012 | |
| Lorenz | Studer | MD, Founding Director, Center for Stem Cell Biology | Memorial Sloan-Kettering Cancer Center | 2015 |
| Anthony | Sun | Partner | Aisling Capital | 2012 |
| Kevin | Tabb | MD, chief medical officer | Stanford Hospital & Clinics. | 2011 |
| Marry | Tanner | Managing Director | Peter J. Solomon Company | 2010 |
| Marc | Tessier-Lavigne | Chair, PhD, President, Professor Laboratory of Brain Development and Repair | The Rockefeller University, New York | 2014 / 2015 |
| Marc | Tessier-Lavigne | Dr, President, Professor Laboratory of Brain Development and Repair | The Rockfeller University | 2013 |
| William | Thies | M.D., Chief Medical and Scientific Officer | Alzheimer’s Association | 2012 |
| John | Thomas Potts Jr | Dr, Distinguished Jackson Professor of Clinical Medecine, | Massachussets General Hospital and Harvard Medical School | 2013 |
| Craig | Thompson | MD, President & CEO | Memorial Sloan Kettering Cancer Center | 2016 |
| Nancy | Thornberry | Chair, Chief Executive Officer | Kallyope | 2018 |
| Eric | Topol | MD, Executive Vice President and Chair, Innovative Medicine Scripps Research; Director & Founder, Scripps Research Translational Institute; Author, Deep Learning | 2019 | |
| Olivia | Tournay Flatto | PhD, Executive Director | Pershing Square Sohn Cancer Research Alliance | 2014 |
| Kevin J. | Tracey | MD, President and CEO | Feinstein Institute for Medical Research | 2015 |
| Nathan | Turner | Co-Founder | Flatiron Health, Inc. | 2014 |
| Stephen J. | Ubl | President and Chief Executive Officer | PhRMA | 2017 |
| P. Roy | Vagelos | MD, Chair, Retired Chairman and CEO, Merck & Co., Inc. Chairman of the Board | Regeneron Pharmaceuticals, Inc. Committee Chairman | 2012 / 2013 / 2014 / 2015 / 2016 / 2017 |
| Rajeev | Venkayya | MD, President, Vaccine Business Unit | Takeda Pharmaceutical Company, Ltd. | 2017 |
| Philip | Vickers | PhD, Global Head of Research & Development | Shire plc | 2016 |
| Chris | Viehbacher | CEO, Sanofi; Chairman | Genzyme | 2014 |
| Jan T. | Vilcek | M.D | New York University School of Medicine | 2011 |
| Bert | Vogelstein | Dr, Professor | Johns Hopkins School of Medicine | 2013 |
| Robert | Vonderheide | MD, DPhil, Professor of Clinical Research, Perelman School of Medicine | University of Pennsylvania | 2014 |
| Sihong | Wang | PhD, Professor | City University of New York City College | 2014 |
| Ryan | Watts | PhD, CEO | Denali Therapeutics | 2015 / 2017 |
| Christophe | Weber | PharmD, Representative Director, President & Chief Executive Officer | Takeda | 2019 |
| Gerald | Weissmann | M.D, Committee Chairman | New York University School of Medicine | 2011 |
| Robert M. | Wenham | MD, MS, FACOG, FACS, Principal Investigator, Total Cancer Care Programs of Gynecologic Oncology & Experimental Therapeutics | Moffitt Cancer Center | 2011 |
| Steve | Whitehead | PhD, Senior Associate Scientist, Laboratory of Infectious Diseases | NIH National Institute for Allergies & Infectious Diseases | 2017 |
| Elie | Wiesel | Pr, Honorary Member, Peace Nobel Laureate | Boston University | 2011 / 2012 / 2013 |
| Ron | Winslow | Senior Medical and Health Care Writer | WSJ Deputy Editor, Health and Science | 2011 |
| Amanda | Woerman | PhD, Assistant Professor of Neurology | Institute for Neurodegenerative Diseases, (UCSF) | 2017 |
| Joanna | Wolkowski | MBA, Vice-President, Portfolio & Decision Analysis | Pfizer | 2019 |
| George | Yancopoulos | MD, PhD, Chief Scientific Officer | Regeneron Pharmaceuticals | 2016 / 2017 |
| Krishna | Yeshvant | MD, General Partner | Google Ventures | 2014 |
| Jide | Zeitlan | CEO | Keffi Group | 2011 |
| Elias | Zerhouni | MD, President, Global R&D | Sanofi | 2014 |
| Feng | Zhang | PhD, W. M. Keck Career Development Professor of Biomedical Engineering | MIT | 2015 |
| Bernard | Zinman | MD, Director, Leadership Sinai Centre for Diabetes | Mount Sinai Hospital, Toronto, Ontario | 2016 |
| Huda | Zoghbi | Dr, Professor | Baylor College of Medicine | 2013 |
| Lynne | Zydowsky | Chief Science Officer, Alexandria Real, Estate Equities, Inc./ Alexandria Venture Investments; President and Co-Founder Alexandria Summit | Alexandria | 2011 / 2014 / 2015 / 2016 / 2017 / 2018 / 2019 |